|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/495 | (2006.01) |
| A61P 9/06 | (2006.01) |
| (11) | Number of the document | 1490066 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03723907.6 |
| Date of filing the European patent application | 2003-04-04 | |
| (97) | Date of publication of the European application | 2004-12-29 |
| (45) | Date of publication and mention of the grant of the patent | 2008-06-11 |
| (46) | Date of publication of the claims translation | 2008-10-27 |
| (86) | Number | PCT/US2003/010434 |
| Date | 2003-04-04 |
| (87) | Number | WO 2003/086401 |
| Date | 2003-10-23 |
| (30) | Number | Date | Country code |
| 370150 P | 2002-04-04 | US | |
| 408292 P | 2002-09-05 | US | |
| 422589 P | 2002-10-30 | US |
| (72) |
BELARDINELLI, Luiz, US
ANTZELEVITCH, Charles, US
BLACKBURN, Brent, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Ranolazino panaudojimas medikamento, skirto aritmijų gydymui, gamyboje |
| USE OF RANOLAZINE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ARRHYTHMIAS |
| Payment date | Validity (years) | Amount | |
| 2019-03-19 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-04-04 |